Today, the National Perinatal Association (NPA) issued a formal position of support for both the Senate and House versions of the Promoting Life-Saving New Therapies for Neonates Act. The NPA is a non-profit organization dedicated to giving a voice to the needs of pregnant women, infants, their families, and their healthcare providers to generate a positive impact on perinatal care in the United States. Support from the NPA's diverse membership adds to the growing support for the bill among the patient and health professional communities.
"We must recognize and respond to this unmet need and speak up for those who have no voice," the NPA's statement explains. "Without our efforts on their behalf, many sick and preterm infants may never reach adulthood."
"Therefore, the National Perinatal Association endorses [the] Promoting Life-Saving New Therapies for Neonates Act of 2015 in the hopes that these long-neglected and vulnerable patients will be the recipients of therapeutic advances to improve their long-term survival and outcome."
The full statement of support for both the House and Senate versions of the bill are below.
"Therefore, the National Perinatal Association endorses [the] Promoting Life-Saving New Therapies for Neonates Act of 2015 in the hopes that these long-neglected and vulnerable patients will be the recipients of therapeutic advances to improve their long-term survival and outcome."
The full statement of support for both the House and Senate versions of the bill are below.
| NPA Position of Support - H.R. 5182 |
| NPA Position of Support - S. 2041 |
